Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Microbot Medical (MBOT) Net Income (2016)

Microbot Medical's Net Income history spans 7 years, with the latest figure at -$1.9 million for Q3 2016.

  • For the quarter ending Q3 2016, Net Income rose 81.25% year-over-year to -$1.9 million, compared with a TTM value of -$20.6 million through Dec 2016, up 44.63%, and an annual FY2020 reading of -$9.2 million, down 24.87% over the prior year.
  • Net Income for Q3 2016 was -$1.9 million at Microbot Medical, up from -$8.9 million in the prior quarter.
  • The five-year high for Net Income was -$58000.0 in Q1 2014, with the low at -$10.1 million in Q3 2015.
  • Average Net Income over 5 years is -$4.2 million, with a median of -$5.1 million recorded in 2012.
  • Year-over-year, Net Income skyrocketed 98.7% in 2013 and then plummeted 15666.12% in 2015.
  • Tracing MBOT's Net Income over 5 years: stood at -$6.2 million in 2012, then surged by 98.13% to -$115000.0 in 2013, then rose by 3.48% to -$111000.0 in 2014, then tumbled by 7616.7% to -$8.6 million in 2015, then soared by 77.91% to -$1.9 million in 2016.
  • Per Business Quant, the three most recent readings for MBOT's Net Income are -$1.9 million (Q3 2016), -$8.9 million (Q2 2016), and -$9.8 million (Q1 2016).